SEC 13F Intelligence

Bridger Management, LLC / XENE

Bridger Management, LLC’s Xenon Pharmaceuticals Inc Position

Does Bridger Management, LLC own Xenon Pharmaceuticals Inc (XENE)? Not currently — the last reported position was 146.8K shares worth $5M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q1 2025
Shares
146.8K
% of Portfolio
+2.45%
Quarters Held
8
position exited

Position History XENE

Reported value by quarter
Q2 ’22: $2MQ2 ’22Q3 ’22: $2MQ3 ’22Q4 ’23: $7MQ4 ’23Q1 ’24: $6MQ1 ’24Q2 ’24: $6MQ2 ’24Q3 ’24: $6MQ3 ’24Q4 ’24: $6MQ4 ’24Q1 ’25: $5MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025146.8K$5M+2.45%
Q4 2024146.8K$6M+3.09%
Q3 2024146.8K$6M+2.89%
Q2 2024146.8K$6M+2.95%
Q1 2024146.8K$6M+2.85%
Q4 2023146.8K$7M+2.61%
Q3 202245.2K$2M+0.50%
Q2 202277.4K$2M+0.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridger Management, LLC’s full portfolio or all institutional holders of XENE.